Alzchem Group Ag Stock Current Ratio
| ACT Stock | EUR 57.40 0.20 0.35% |
AlzChem Group AG fundamentals help investors to digest information that contributes to AlzChem Group's financial success or failures. It also enables traders to predict the movement of AlzChem Stock. The fundamental analysis module provides a way to measure AlzChem Group's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to AlzChem Group stock.
AlzChem |
AlzChem Group AG Company Current Ratio Analysis
AlzChem Group's Current Ratio is calculated by dividing the Current Assets of a company by its Current Liabilities. It measures whether or not a company has enough cash or liquid assets to pay its current liability over the next fiscal year. The ratio is regarded as a test of liquidity for a company.
Typically, short-term creditors will prefer a high current ratio because it reduces their overall risk. However, investors may prefer a lower current ratio since they are more concerned about growing the business using assets of the company. Acceptable current ratios may vary from one sector to another, but the generally accepted benchmark is to have current assets at least as twice as current liabilities (i.e., Current Ration of 2 to 1).
| Competition |
In accordance with the recently published financial statements, AlzChem Group AG has a Current Ratio of 0.0 times. This indicator is about the same for the average (which is currently at 0.0) sector and about the same as Current Ratio (which currently averages 0.0) industry. This indicator is about the same for all Germany stocks average (which is currently at 0.0).
Did you try this?
Run Top Crypto Exchanges Now
Top Crypto ExchangesSearch and analyze digital assets across top global cryptocurrency exchanges |
| All Next | Launch Module |
AlzChem Fundamentals
| Current Valuation | 261.71 M | |||
| Price To Book | 1.35 X | |||
| Price To Sales | 0.37 X | |||
| Revenue | 422.29 M | |||
| EBITDA | 62.69 M | |||
| Net Income | 27.59 M | |||
| Total Debt | 37.55 M | |||
| Cash Flow From Operations | 43.02 M | |||
| Market Capitalization | 249.32 M | |||
| Total Asset | 377.67 M | |||
| Z Score | 4.6 | |||
| Annual Yield | 0.03 % | |||
| Net Asset | 377.67 M | |||
| Last Dividend Paid | 0.75 |
About AlzChem Group Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze AlzChem Group AG's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of AlzChem Group using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of AlzChem Group AG based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for AlzChem Stock Analysis
When running AlzChem Group's price analysis, check to measure AlzChem Group's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy AlzChem Group is operating at the current time. Most of AlzChem Group's value examination focuses on studying past and present price action to predict the probability of AlzChem Group's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move AlzChem Group's price. Additionally, you may evaluate how the addition of AlzChem Group to your portfolios can decrease your overall portfolio volatility.